Trade between India and Russia has the potential to reach $10.0 billion in 2010 and $20.0 billion by 2015 but there are obstacles that need to be addressed for this to occur, reports the New Kerala newspaper. Among the problems noted are that the registration process for generic drugs in Russia takes almost two years, while Indian firms' filings of products from eastern European drugmakers were normally cleared in about a year.
Drugmakers fear boycott of pharmacies
Separately, Indian drugmakers are reportedly refusing to sell their products directly to retail chains because of concerns over a pharmacy boycott. The move came from the All India Organization of Chemists and Druggists which are both retail and wholesale members.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze